Publications
- Cardiometabolic Risk in Patients with Schizophrenia2010 | Faculty of Medicine in Hradec Králové
- Pharmacological treatment of severe dyslipidaemia in patients with schizophrenia +12007 | Faculty of Medicine in Hradec Králové
- Treatment With Rosuvastatin for Severe Dyslipidemia in Patients With Schizophrenia and Schizoaffective Disorder +12006 | Faculty of Medicine in Hradec Králové
- Treatment With Rosuvastatin for Severe Dyslipidemia in Patients With Schizophrenia and Schizoaffective Disorder2006 | First Faculty of Medicine
- Peripheral endothelial dysfunction as a marker of cardiovascular risk in physically healthy patients with schizophrenia and related psychoses: A matched case control study2014 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Effect of adjunctive treatment with aripiprazole on metabolic symptoms in schizophrenia patients treated with clozapine2013 | Faculty of Medicine in Hradec Králové
- The prevalence of cardiometabolic risk factors and the ten-year risk of fatal cardiovascular events in patients with schizophrenia and related psychotic disorders2012 | Faculty of Medicine in Hradec Králové
- Cognitive changes in spinocerebellar ataxia type 22011 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Physical Education and Sport
- OMI-Salzburg medical seminars interantional2011 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Examination of a patient with neuropsychiatric disorder2011 | Faculty of Medicine in Hradec Králové
Loading network view...